News blog
First embryonic stem cell trial approved outside the US
An embryonic field seems to be developing rapidly. Just two months after Advanced Cell Technology (ACT) launched the second and third trials involving products derived from human embryonic stem cells (ESCs) in an operating room at the University of California–Los Angeles, the Santa Monica-based biotech announced today that it had gained approval from the UK Medicines and Healthcare products Regulatory Agency to conduct the first ESC cell trial outside the US.
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells